Open AccessHead and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictors
Author(s) -
Supreet Singh Nayyar,
Shivakumar Thiagarajan,
Akshat Malik,
Anil D’Cruz,
Devendra A Chaukar,
Prachi Patil,
Aruna Dhir Alahari,
Sarbani Ghosh Lashkar,
Kumar Prabhash
Publication year - 2020
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_166_19
Subject(s) - medicine , head and neck squamous cell carcinoma , stage (stratigraphy) , retrospective cohort study , hepatitis c virus , cohort , hepatitis b virus , oncology , gastroenterology , immunology , head and neck cancer , cancer , virus , paleontology , biology
Patients receiving treatment for head-and-neck squamous cell carcinoma (HNSCC) also may have coexisting viral infections caused by HIV, HBV, and HCV (seropositive). There is scarce literature regarding the clinical presentation and treatment outcomes for these patients with coexisting viral infections (seropositive HNSCC). We conducted this study to assess the clinical presentation and treatment outcomes (overall survival [OS] and disease-specific survival [DSS]) of seropositive HNSCC patients.